Anti-Osteocalcin antibody [EPR3690]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(71 Publications)
Rabbit Recombinant Monoclonal Osteocalcin antibody. Suitable for WB and reacts with Human, Recombinant full length protein - Human samples. Cited in 71 publications.
View Alternative Names
Osteocalcin, Bone Gla protein, Gamma-carboxyglutamic acid-containing protein, BGP, BGLAP
- WB
Lab
Western blot - Anti-Osteocalcin antibody [EPR3690] (AB133612)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Western blot - Anti-Osteocalcin antibody [EPR3690] (ab133612) at 1/1000 dilution
All lanes:
Human articular cartilage tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/1000 dilution
Predicted band size: 11 kDa
Observed band size: 19 kDa
true
Exposure time: 158s
- WB
Unknown
Western blot - Anti-Osteocalcin antibody [EPR3690] (AB133612)
All lanes:
Western blot - Anti-Osteocalcin antibody [EPR3690] (ab133612) at 1/1000 dilution
All lanes:
Human Osteocalcin recombinant protein at 0.01 µg
Predicted band size: 11 kDa
false
- WB
Unknown
Western blot - Anti-Osteocalcin antibody [EPR3690] (AB133612)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Osteocalcin antibody [EPR3690] (ab133612) at 1.2 µg/mL
All lanes:
Human osteocalcin recombinant protein at 0.015 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 11 kDa
false
Related conjugates and formulations (1)
-
Anti-Osteocalcin antibody [EPR3690] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Osteocalcin plays a significant role in regulating glucose metabolism and fat deposition. It acts as a hormone from the bone and influences energy metabolism and insulin sensitivity. Osteocalcin undergoes carboxylation a post-translational modification necessary for its function in bone. Beyond its structural role demineralized osteocalcin has been found to impact pancreatic β-cell function adipose tissue and male fertility although the pathways in these processes are not entirely understood yet.
Pathways
Osteocalcin is associated with the energy metabolism and bone remodeling pathways. It interacts with the insulin signaling pathway influencing insulin secretion by pancreatic β-cells and boosting insulin sensitivity. This interaction involves proteins like insulin receptor substrate 1 (IRS1) and glucose transporter type 4 (GLUT4) which play roles in glucose uptake. Osteocalcin also connects to bone remodeling pathways by influencing osteoclast differentiation and activity through osteoprotegrin and receptor activator of nuclear factor kappa-B ligand (RANKL).
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (71)
Recent publications for all applications. Explore the full list and refine your search
Journal of orthopaedic surgery and research 18:820 PubMed37915040
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 26:531 PubMed37869648
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of periodontal research 58:1248-1260 PubMed37767803
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107923 PubMed37810257
2023
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 102:1489-1505 PubMed37690812
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 38:1480-1496 PubMed37537994
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 18:546 PubMed37516879
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 21:193 PubMed37316836
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 55:587-596 PubMed36869070
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36769123
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com